Kennedy R. Lees
University of Glasgow
467 Papers
3.9K Citations
Kennedy R. Lees is an academic researcher from University of Glasgow. The author has contributed to research in topics: Stroke & Medicine. The author has an hindex of 86, co-authored 455 publications. Previous affiliations of Kennedy R. Lees include Ludwig Maximilian University of Munich & Cedars-Sinai Medical Center.
Chat about Author
Papers
Transcranial Laser Therapy in Acute Stroke Treatment Results of Neurothera Effectiveness and Safety Trial 3, a Phase III Clinical End Point Device Trial
Werner Hacke,Peter D. Schellinger,Gregory W. Albers,Natan M. Bornstein,Björn Dahlöf,Rachael L. Fulton,Scott E. Kasner,Ashfaq Shuaib,Steven P. Richieri,Stephen G. Dilly,Justin A. Zivin,Kennedy R. Lees,Justin A. Zivin,Joseph P. Broderick,Anastasia Ivanova,Karen C. Johnston,Bo Norrving,Greg Albars,Andrei V. Alexandrov,David M. Brown,Patrick Capone,David Chiu,Wayne M. Clark,Jack Cochran,Colin Deredyn,Thomas Devlin,William Hickling,George Howell,David Y. Huang,Shazam Hussain,Sidney Mallenbaum,Majaz Moonis,Marshall Nash,Marilyn M. Rymer,Reid Taylor,Margaret Tremwel,Brian Buck,Julio Perez,Christian Gerloff,Bernd Greiwing,Martin Grond,Gerhard Hamman,Thomas Haarmeiter,Sebastian Jander,Martin Köhrmann,Martin A. Ritter,Peter Schallinger,Dietmar Schneider,Jan Sobesky,Thorsten Steiner,Helmuth Steinmetz,Roland Veltkamp,Christian Weimar,Franz Gruber,Björn Andersson,Lennart Welin,Didier Leys,Turgut Tatlisumak,Andreas R. Luft,Philippe Lyrer,Patrik Michel,Carlos A. Molina,Tomás Segura +62 more
TL;DR: It is concluded that transcranial laser therapy does not have a measurable neuroprotective effect in patients with acute ischemic stroke when applied within 24 hours after stroke onset.
106
Tolerability and Pharmacokinetics of the Nitrone NXY-059 in Patients With Acute Stroke
TL;DR: NXY-059 was well tolerated in patients with an acute stroke, and the testing of higher doses in future trials may be justified.
98
Effect of Area-Based Deprivation on the Severity, Subtype, and Outcome of Ischemic Stroke
TL;DR: Tackling health inequalities in stroke should focus on stroke primary prevention by tackling deprivation, including promoting changes in lifestyle.
96
Thrombolysis is associated with consistent functional improvement across baseline stroke severity: a comparison of outcomes in patients from the Virtual International Stroke Trials Archive (VISTA).
TL;DR: Outcomes after thrombolysis were significantly better than in untreated comparators across baseline NIHSS 5 to 24, and the significant association was lost only at extremes of baseline NIH SS when sample sizes were small and confidence limits were wide.
96
Allopurinol Use Yields Potentially Beneficial Effects on Inflammatory Indices in Those With Recent Ischemic Stroke : A Randomized, Double-Blind, Placebo-Controlled Trial
Scott Muir,Craig Harrow,Jesse Dawson,Kennedy R. Lees,Christopher J. Weir,Naveed Sattar,Matthew Walters +6 more
TL;DR: Allopurinol treatment is well tolerated and attenuates the rise in intercellular adhesion molecule-1 levels seen after stroke, which support further evaluation of allopur inol as a preventive measure after stroke.
95